甲状腺癌放射性碘消融术后白血病风险的相关性存疑 - Suppr | 超能文献

Questionable Relevance of Leukemia Risk After Radioiodine Ablation of Thyroid Cancer.

作者信息

Fisher Ronald

机构信息

Ronald Fisher, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX.

出版信息

J Clin Oncol. 2018 Jun 20;36(18):1885. doi: 10.1200/JCO.2018.78.1534. Epub 2018 May 3.

DOI:10.1200/JCO.2018.78.1534

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Questionable Relevance of Leukemia Risk After Radioiodine Ablation of Thyroid Cancer.甲状腺癌放射性碘消融术后白血病风险的相关性存疑

J Clin Oncol. 2018 Jun 20;36(18):1885. doi: 10.1200/JCO.2018.78.1534. Epub 2018 May 3.

2

Risk of Hematologic Malignancies After Radioactive Iodine Treatment of Thyroid Cancer: An Unjustified Warning.甲状腺癌放射性碘治疗后血液系统恶性肿瘤的风险：一个不合理的警告。

J Clin Oncol. 2018 Jun 20;36(18):1881-1882. doi: 10.1200/JCO.2018.78.1096. Epub 2018 May 3.

3

[Total thyroidectomy without radioiodine ablation for low-risk thyroid cancer].[低危甲状腺癌的全甲状腺切除术且不进行放射性碘消融治疗]

Chirurg. 2016 Aug;87(8):698. doi: 10.1007/s00104-016-0203-4.

4

A prospective clinical trial to assess the efficacy of radioiodine ablation as an alternative to completion thyroidectomy in patients with differentiated thyroid cancer undergoing sub-total thyroidectomy.一项前瞻性临床试验，旨在评估放射性碘消融作为接受甲状腺次全切除术的分化型甲状腺癌患者甲状腺全切术替代方案的疗效。

Acta Oncol. 2006;45(8):1067-72. doi: 10.1080/02841860500418377.

5

Quantitative approach to radioiodine ablation of thyroid remnants following surgery for thyroid cancer.甲状腺癌手术后甲状腺残余组织放射性碘消融的定量方法。

Radiobiol Radiother (Berl). 1985;26(6):819-23.

6

Radioiodine ablation of residual tissue in thyroid cancer: relationship between administered activity, neck uptake and outcome.甲状腺癌残留组织的放射性碘消融：给药活度、颈部摄取与预后的关系。

Br J Radiol. 1994 Nov;67(803):1127-31. doi: 10.1259/0007-1285-67-803-1127.

7

Well-Founded Recommendations for Radioactive Iodine Treatment of Differentiated Thyroid Cancer Require Balanced Study of Benefits and Harms.关于分化型甲状腺癌放射性碘治疗的有充分依据的建议需要对益处和危害进行平衡研究。

J Clin Oncol. 2018 Jun 20;36(18):1887-1888. doi: 10.1200/JCO.2018.78.5972. Epub 2018 May 3.

8

[Is radioiodine ablation of residual thyroid tissue indicated after an operation for differentiated thyroid cancer?].[分化型甲状腺癌手术后是否需要对残留甲状腺组织进行放射性碘消融？]

Lik Sprava. 1997 Jan-Feb(1):118-22.

9

Fractionated dosage of radioiodine for the ablation of low-risk differentiated thyroid cancer has no impact on survival.低危分化型甲状腺癌消融的放射性碘分次给药对生存无影响。

Endokrynol Pol. 2018;69(3):230-234. doi: 10.5603/EP.a2018.0017. Epub 2018 Mar 5.

10

Effect of a Low Iodine Diet vs. Restricted Iodine Diet on Postsurgical Preparation for Radioiodine Ablation Therapy in Thyroid Carcinoma Patients.低碘饮食与限制碘饮食对甲状腺癌患者放射性碘消融治疗术后准备的影响

Yonsei Med J. 2015 Jul;56(4):1021-7. doi: 10.3349/ymj.2015.56.4.1021.

引用本文的文献

1

Analysis of Short-Term and Stable DNA Damage in Patients with Differentiated Thyroid Cancer Treated with I in Hypothyroidism or with Recombinant Human Thyroid-Stimulating Hormone for Remnant Ablation.分化型甲状腺癌患者在甲状腺功能减退症中或用重组人促甲状腺激素进行残余消融治疗时的短期和稳定 DNA 损伤分析。

J Nucl Med. 2022 Oct;63(10):1515-1522. doi: 10.2967/jnumed.121.263442. Epub 2022 Feb 3.

2

An introduction to the clinical practice of theranostics in oncology.肿瘤诊疗一体化临床实践介绍。

Br J Radiol. 2018 Nov;91(1091):20180440. doi: 10.1259/bjr.20180440. Epub 2018 Sep 4.